| Literature DB >> 33262923 |
S Olaniyi1, O S Obabiyi2, K O Okosun3, A T Oladipo1, S O Adewale1.
Abstract
The novel coronavirus disease (COVID-19) caused by a new strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains the current global health challenge. In this paper, an epidemic model based on system of ordinary differential equations is formulated by taking into account the transmission routes from symptomatic, asymptomatic and hospitalized individuals. The model is fitted to the corresponding cumulative number of hospitalized individuals (active cases) reported by the Nigeria Centre for Disease Control (NCDC), and parameterized using the least squares method. The basic reproduction number which measures the potential spread of COVID-19 in the population is computed using the next generation operator method. Further, Lyapunov function is constructed to investigate the stability of the model around a disease-free equilibrium point. It is shown that the model has a globally asymptotically stable disease-free equilibrium if the basic reproduction number of the novel coronavirus transmission is less than one. Sensitivities of the model to changes in parameters are explored, and safe regions at certain threshold values of the parameters are derived. It is revealed further that the basic reproduction number can be brought to a value less than one in Nigeria, if the current effective transmission rate of the disease can be reduced by 50%. Otherwise, the number of active cases may get up to 2.5% of the total estimated population. In addition, two time-dependent control variables, namely preventive and management measures, are considered to mitigate the damaging effects of the disease using Pontryagin's maximum principle. The most cost-effective control measure is determined through cost-effectiveness analysis. Numerical simulations of the overall system are implemented in MatLab ® for demonstration of the theoretical results. © Società Italiana di Fisica and Springer-Verlag GmbH Germany, part of Springer Nature 2020.Entities:
Year: 2020 PMID: 33262923 PMCID: PMC7688301 DOI: 10.1140/epjp/s13360-020-00954-z
Source DB: PubMed Journal: Eur Phys J Plus ISSN: 2190-5444 Impact factor: 3.911
Fig. 1A flowchart of COVID-19 model with
The parameters of the COVID-19 model (1)
| Parameter | Description |
|---|---|
| Effective transmission coefficient | |
| Modification parameter for a reduced transmission from asymptomatic humans | |
| Modification parameter for a more reduced transmission from hospitalized class | |
| Rate of disease progression from exposed class | |
| Proportion of exposed with symptoms after the incubation period | |
| Proportion of exposed without symptoms after the incubation period | |
| Hospitalization rate for symptomatic class | |
| Hospitalization rate for asymptomatic class after confirmation | |
| Recovery rate for symptomatic class | |
| Recovery rate for asymptomatic class | |
| Recovery rate for hospitalized class | |
| Disease-induced mortality rate for symptomatic class | |
| Disease-induced mortality rate for hospitalized class |
Values of parameters and initial conditions
| Parameter | Range | Value | Source |
|---|---|---|---|
| 0–1 | 0.38974 | Fitted | |
| 0.5 | [ | ||
| 0–1 | 0.24278 | Fitted | |
| [ | |||
| 0–1 | 0.5 | [ | |
| 0.2–0.5 | 0.33604 | Fitted | |
| 0.1–0.25 | 0.19466 | Fitted | |
| 0.0333–0.3333 | [ | ||
| 0.0333–0.3333 | [ | ||
| 0.001–0.1 | 0.015 | [ |
Fig. 2Fitting of the COVID-19 model (1) with the available cumulative number of active cases from March 10 to July 15, 2020
Fig. 3COVID-19 model sensitivities to its associated parameters
Fig. 42-D contour plots of the basic reproduction number
Fig. 5Projections with varying effects of parameters: a Effective transmission coefficient at values of . b Recovery rate for hospitalized individuals at values of
Fig. 6Relationship between COVID-19 epidemiological threshold and parameters
Fig. 7Convergence of solution trajectories for a symptomatic humans, b asymptomatic humans and c hospitalized humans at different initial sizes in line with Theorem 2. Parameter values used are as given in Table 2 except for and , so that
Fig. 8Control profile () and its effects on the COVID-19 dynamics
Fig. 9Control profile () and its effects on the COVID-19 dynamics
Fig. 10Combined effects of optimal controls , on the COVID-19 dynamics
ICER in the order of COVID-19 cases averted by control measures
| Control measures | Total infection averted | Total costs | ICER |
|---|---|---|---|
| 0.0135 | |||
| 0.1580 | |||
Comparison between and
| Control measures | Total infection averted | Total costs | ICER |
|---|---|---|---|
| 0.0135 | |||
| 0.0072 |